PKD Screening for First-Degree Relatives
For adults at risk of ADPKD due to a first-degree relative with the disease, begin screening with abdominal ultrasound and use age-specific cyst criteria to diagnose or exclude the disease. 1
Screening Protocol
Pre-Screening Counseling
Before any testing, provide counseling about the benefits and risks of screening, including psychological implications, insurance considerations, and the impact on family planning. The individual's values and preferences should guide the decision to proceed with screening. 1
Primary Screening Method: Ultrasound
Abdominal ultrasound is the recommended first-line screening test for at-risk adults. 1 This approach is cost-effective, non-invasive, and has well-established diagnostic criteria.
Age-Specific Ultrasound Diagnostic Criteria:
For ages 15-39 years:
- Diagnosis confirmed: ≥3 total cysts (unilateral or bilateral)
- Diagnosis excluded: ≤1 cyst total
For ages 40-59 years:
- Diagnosis confirmed: ≥2 cysts in each kidney (bilateral)
- Diagnosis excluded: ≤2 cysts total
For age ≥60 years:
- Diagnosis confirmed: ≥4 cysts in each kidney
- Diagnosis excluded: Not well-defined (simple cysts become common with age)
These criteria apply specifically to families with PKD1 or PKD2 mutations and provide excellent sensitivity (88.5% at ages 15-29 years, 100% at age 30+ years) and specificity (approaching 100%). 2
When Initial Ultrasound is Equivocal or Atypical
Follow-up with MRI or Genetic Testing
If ultrasound findings are equivocal, atypical features are present, or additional prognostic information is needed, proceed with:
MRI criteria (ages 16-40 years):
- Diagnosis confirmed: >10 total cysts
- Diagnosis excluded: <5 total cysts
- CT with or without contrast can substitute for MRI 1
Genetic testing is particularly valuable when:
- Few kidney cysts are present
- The individual is a young (<30 years) potential living kidney donor
- Family planning or preimplantation diagnosis is being considered
- There's variable disease severity within the family
- Imaging and kidney function are discordant 1
Genetically Resolved Families
If the family's specific pathogenic variant is known, targeted genetic testing for that variant is usually sufficient to diagnose or exclude ADPKD, bypassing the need for imaging-based criteria. 1 This approach provides definitive diagnosis regardless of age or cyst burden.
Important Caveats
PKD2 Considerations
The ultrasound criteria were primarily validated for PKD1 families. PKD2 has a milder phenotype with later cyst development, so ultrasound sensitivity in younger individuals (<30 years) at risk for PKD2 is lower (67% vs 95% for PKD1). 3 If PKD2 is suspected in the family, consider earlier genetic testing rather than relying solely on ultrasound in younger individuals.
Negative Ultrasound Doesn't Always Exclude Disease
A normal ultrasound in a younger at-risk individual (especially <30 years) does not definitively exclude ADPKD, particularly in PKD2 families or those with milder phenotypes. Cysts develop progressively with age. 4
Screening Children
For children and adolescents under 15 years, one or more kidney cysts on ultrasound is highly suggestive of ADPKD, but established adult criteria don't apply. 4 The decision to screen children should involve careful counseling about psychological impacts and limited clinical utility, as most children are asymptomatic and no disease-modifying treatments are approved for pediatric use.
Practical Algorithm Summary
- Provide pre-screening counseling about implications
- Perform abdominal ultrasound as first-line test
- Apply age-specific cyst criteria to diagnose or exclude
- If equivocal: Proceed to MRI (ages 16-40) or genetic testing
- If genetically resolved family: Consider direct genetic testing for known variant
- If negative in young adult: Consider repeat imaging in 2-3 years or genetic testing if high clinical suspicion
This algorithmic approach balances diagnostic accuracy with cost-effectiveness while accounting for the age-dependent nature of cyst development in ADPKD.